Should You Buy NRX Pharmaceuticals Inc (NRXP) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/26
NRX Pharmaceuticals Inc (NRXP) is not a good buy at the moment for a beginner investor with a long-term strategy. The stock is currently in a bearish trend with no strong positive catalysts in the near term. The technical indicators suggest a downward momentum, and the options data reflects bearish sentiment. While analysts have a positive long-term outlook for 2026, there are no immediate drivers for growth or significant events to justify a buy at this time.
Technical Analysis
The technical indicators show a bearish trend. The MACD is negative and expanding downward, the RSI is neutral at 40.401, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels, with the next support at 2.051. The overall trend suggests further downside potential in the short term.
Analyst Ratings and Price Target Trends
Analysts maintain a Buy rating with a price target increase from $47 to $48, citing long-term opportunities tied to FDA approvals in 2026. However, there are no immediate catalysts to drive the stock higher in the short term.
Wall Street analysts forecast NRXP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NRXP is 37.67 USD with a low forecast of 25 USD and a high forecast of 48 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast NRXP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NRXP is 37.67 USD with a low forecast of 25 USD and a high forecast of 48 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Current: 2.110
Current: 2.110
